Quarterly
Annual
| Unit: USD | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2017-12-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | |||||||||||||||||||
net income | 3,288,000 | 2,282,000 | 660,000 | 2,688,000 | 2,041,000 | 2,186,000 | 33,000 | 1,752,000 | 1,107,000 | 1,210,000 | -41,194,000 | 2,827,000 | 2,981,000 | ||||||
adjustments to reconcile net income to net cash from operating activities | |||||||||||||||||||
depreciation | |||||||||||||||||||
benefit from credit losses on non-consumer fintech loans | |||||||||||||||||||
benefit from credit losses on consumer fintech loans | |||||||||||||||||||
provision reversal for unfunded commitments | |||||||||||||||||||
net accretion of investment securities discounts/premiums | |||||||||||||||||||
stock-based compensation expense | 2,698,000 | 2,041,000 | 2,103,000 | 845,000 | 524,000 | 462,000 | 398,000 | 416,000 | 218,000 | 23,000 | 74,000 | 26,000 | 26,000 | 27,000 | 28,000 | 28,000 | 15,000 | ||
realized gains on commercial loans, at fair value | |||||||||||||||||||
gain on sale of fixed assets | 94,000 | ||||||||||||||||||
gain on sale of other real estate owned | |||||||||||||||||||
change in fair value of derivatives | 143,000 | 544,000 | -343,000 | ||||||||||||||||
loss on sales/calls of investment securities | |||||||||||||||||||
increase in accrued interest receivable | -3,375,000 | -6,499,000 | -482,000 | -14,000 | -1,084,000 | ||||||||||||||
increase in other assets | 6,637,000 | 3,761,000 | -10,814,000 | 1,460,000 | 1,775,000 | -539,000 | -1,571,000 | 3,370,000 | -6,975,000 | -1,683,000 | |||||||||
increase in consumer fintech loan credit enhancement receivables | |||||||||||||||||||
increase in other liabilities | 858,000 | 25,174,000 | -2,132,000 | 5,842,000 | -4,107,000 | -21,070,000 | 23,046,000 | 1,983,000 | 1,858,000 | 270,000 | -3,040,000 | 1,238,000 | 655,000 | -979,000 | 1,134,000 | ||||
net cash from operating activities | 61,353,000 | 52,674,000 | 12,500,000 | -108,757,000 | 7,206,000 | 15,274,000 | 1,816,000 | 13,344,000 | 2,831,000 | -13,752,000 | 20,936,000 | 9,018,000 | 7,198,000 | 10,019,000 | -7,322,000 | 4,177,000 | 1,559,000 | 4,162,000 | 9,096,000 |
investing activities | |||||||||||||||||||
purchase of investment securities available-for-sale | 0 | -4,862,000 | -12,101,000 | -342,055,000 | -61,895,000 | -89,392,000 | -115,266,000 | -79,256,000 | -11,284,000 | -99,493,000 | -39,998,000 | ||||||||
proceeds from redemptions and prepayments of securities available-for-sale | 15,931,000 | 33,736,000 | 105,889,000 | 44,127,000 | |||||||||||||||
capitalized investment in other real estate owned | |||||||||||||||||||
sale of repossessed assets | 1,256,000 | 948,000 | |||||||||||||||||
proceeds from sale of other real estate owned | 3,756,000 | 0 | 0 | 125,000 | 596,000 | 173,000 | 0 | 0 | |||||||||||
net increase in loans | -220,825,000 | -610,542,000 | -20,369,000 | -33,117,000 | -44,861,000 | -48,915,000 | -21,472,000 | -32,525,000 | -6,883,000 | -14,112,000 | -56,513,000 | 8,196,000 | -23,176,000 | 18,464,000 | -76,087,000 | -26,448,000 | |||
proceeds from sale of fixed assets | 579,000 | 23,000 | 6,000 | 39,000 | |||||||||||||||
commercial loans, at fair value drawn during the period | -29,064,000 | -29,190,000 | |||||||||||||||||
payments on commercial loans, at fair value | 66,373,000 | 227,321,000 | 294,091,000 | ||||||||||||||||
purchases of premises and equipment | -320,000 | -639,000 | -312,000 | 110,000 | -716,000 | -619,000 | -353,000 | -418,000 | -893,000 | -861,000 | -867,000 | -365,000 | -353,000 | -911,000 | -1,919,000 | -1,132,000 | -210,000 | -843,000 | -722,000 |
net cash from investing activities | -78,115,000 | 8,836,000 | -282,539,000 | -76,723,000 | -65,604,000 | -108,426,000 | -118,979,000 | -62,659,000 | -22,982,000 | -70,052,000 | 8,366,000 | -51,977,000 | -22,939,000 | -26,790,000 | 20,306,000 | -43,496,000 | -69,716,000 | -80,975,000 | -82,781,000 |
financing activities | |||||||||||||||||||
net increase in deposits | 176,439,000 | 118,810,000 | 864,399,000 | -390,950,000 | 910,798,000 | -368,406,000 | 507,012,000 | -398,290,000 | 207,774,000 | -120,966,000 | 284,990,000 | 66,233,000 | 144,762,000 | 59,597,000 | -23,548,000 | 172,394,000 | |||
net decrease in securities sold under agreements to repurchase | 37,000 | -1,698,000 | -970,000 | -6,055,000 | |||||||||||||||
proceeds from short-term borrowings | 25,000,000 | ||||||||||||||||||
proceeds of senior debt offering | |||||||||||||||||||
redemption of senior notes | |||||||||||||||||||
proceeds from the issuance of common stock | -1,000 | 158,000 | 95,000 | ||||||||||||||||
repurchases of common stock and excise tax | |||||||||||||||||||
net cash from financing activities | 151,438,000 | 103,967,000 | 554,494,000 | 695,484,000 | -383,696,000 | 915,597,000 | -367,958,000 | 430,940,000 | -257,335,000 | 67,778,000 | -19,835,000 | 303,852,000 | 50,238,000 | 104,240,000 | 38,928,000 | 75,247,000 | |||
net decrease in cash and cash equivalents | -16,026,000 | -53,730,000 | -41,677,000 | ||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 0 | 0 | |||||||||||||||
cash and cash equivalents, end of period | 134,676,000 | 165,477,000 | 284,455,000 | 822,445,000 | -485,121,000 | 853,944,000 | |||||||||||||
supplemental disclosure: | |||||||||||||||||||
interest paid | 38,796,000 | 27,522,000 | 1,366,000 | 4,150,000 | 2,965,000 | 3,113,000 | 3,145,000 | 2,814,000 | 3,314,000 | 3,967,000 | 3,592,000 | 4,132,000 | 4,108,000 | 6,562,000 | 7,831,000 | 12,369,000 | 10,950,000 | 12,168,000 | 13,238,000 |
taxes paid | 14,568,000 | 7,619,000 | 13,284,000 | 3,108,000 | 1,007,000 | 561,000 | 3,996,000 | 575,000 | -198,000 | 26,000 | 814,000 | 235,000 | 323,000 | 29,000 | 315,000 | 569,000 | 2,787,000 | 1,620,000 | 338,000 |
transfers to other real estate owned from commercial loans, at fair value, and loans | |||||||||||||||||||
leased vehicles transferred to repossessed assets | 2,352,000 | 1,178,000 | 252,000 | ||||||||||||||||
decrease (increase) in accrued interest receivable | -691,000 | -769,000 | 65,000 | -702,000 | -260,000 | ||||||||||||||
decrease (increase) in other assets | -28,066,000 | -10,472,000 | 852,000 | 358,000 | 6,353,000 | ||||||||||||||
decrease in other liabilities | |||||||||||||||||||
provision (reversal) for unfunded commitments | |||||||||||||||||||
net amortization of investment securities discounts/premiums | 320,000 | 348,000 | 242,000 | 3,873,000 | 186,000 | 260,000 | 118,000 | 105,000 | 357,000 | 12,000 | 11,000 | 30,000 | 25,000 | 4,000 | -4,000 | ||||
loss on sale of fixed assets | |||||||||||||||||||
decrease in other assets | 57,000 | ||||||||||||||||||
net increase in cash and cash equivalents | 134,676,000 | 165,477,000 | -442,094,000 | 381,625,000 | -277,486,000 | 9,467,000 | 63,222,000 | 64,921,000 | -29,229,000 | -1,566,000 | -27,853,000 | ||||||||
benefit from credit losses on loans | |||||||||||||||||||
write-down of other real estate owned | |||||||||||||||||||
change in fair value of commercial loans, at fair value | 1,385,000 | 787,000 | 180,000 | ||||||||||||||||
redemption of senior debt | |||||||||||||||||||
non-cash investing and financing activities | |||||||||||||||||||
depreciation and amortization | 1,128,000 | 778,000 | 859,000 | 1,442,000 | 1,057,000 | 1,017,000 | 973,000 | 979,000 | 1,093,000 | 972,000 | 982,000 | 964,000 | 969,000 | 966,000 | 911,000 | 867,000 | 894,000 | 804,000 | 65,000 |
loss on sales of investment securities | 0 | 0 | 0 | ||||||||||||||||
benefit from credit losses on loans and security | |||||||||||||||||||
transfer of real estate owned from commercial loans, at fair value, and loans | |||||||||||||||||||
net income from continuing operations | 40,241,000 | 27,028,000 | -13,332,000 | ||||||||||||||||
net income from discontinued operations, net of tax | |||||||||||||||||||
deferred income tax (benefit) expense | |||||||||||||||||||
gain from discontinued operations | |||||||||||||||||||
loss on sale of other real estate owned | 0 | 0 | 0 | 0 | |||||||||||||||
change in fair value of discontinued assets held-for-sale | 0 | ||||||||||||||||||
net decrease (increase) in loans | -136,047,000 | ||||||||||||||||||
net decrease in discontinued loans held-for-sale | 5,293,000 | ||||||||||||||||||
change in receivable from investment in unconsolidated entity | 0 | ||||||||||||||||||
return of investment in unconsolidated entity | 0 | ||||||||||||||||||
decrease in discontinued assets held-for-sale | 474,000 | ||||||||||||||||||
redemptions of senior debt offering | |||||||||||||||||||
repurchases of common stock | -15,001,000 | -10,000,000 | |||||||||||||||||
non-cash investing and financing activities: | |||||||||||||||||||
transfer of loans from investment in unconsolidated entity upon its dissolution | 0 | ||||||||||||||||||
transfer of real estate owned from investment in unconsolidated entity upon its dissolution | 0 | ||||||||||||||||||
transfer of loans from discontinued operations | 0 | ||||||||||||||||||
transfer of real estate owned from discontinued operations | 0 | ||||||||||||||||||
benefit from credit losses | 2,777,000 | 1,626,000 | |||||||||||||||||
gain on commercial loans, at fair value | -3,601,000 | ||||||||||||||||||
writedown of other real estate owned | |||||||||||||||||||
net decrease in deposits | -43,439,000 | ||||||||||||||||||
investment securities (redeemed) purchased and not settled | |||||||||||||||||||
deferred income tax expense | -3,000 | ||||||||||||||||||
(gain) income from discontinued operations | -54,000 | ||||||||||||||||||
fair value adjustment on investment in unconsolidated entity | 0 | ||||||||||||||||||
net cash paid due to acquisitions, net of cash acquired | |||||||||||||||||||
loans settled in acquisition | |||||||||||||||||||
benefit from (reversal of) credit losses | |||||||||||||||||||
decrease in accrued interest receivable | 71,000 | 133,000 | -627,000 | 661,000 | -229,000 | 1,589,000 | |||||||||||||
commercial loans, at fair value originated or drawn during the period | -65,614,000 | ||||||||||||||||||
investment securities transferred in securitizations | |||||||||||||||||||
net income from discontinued operations | |||||||||||||||||||
(gain) loss on commercial loans, at fair value | |||||||||||||||||||
net decrease in repossessed assets | |||||||||||||||||||
proceeds of short-term borrowings | |||||||||||||||||||
commercial loans, at fair value originated during the period | |||||||||||||||||||
sales and payments on commercial loans, at fair value | |||||||||||||||||||
repurchase of common stock | |||||||||||||||||||
investment securities purchased and not settled | |||||||||||||||||||
transfers of discontinued loans to discontinued other real estate owned | |||||||||||||||||||
loans originated for sale | -123,503,000 | ||||||||||||||||||
sales and payments of commercial loans originated for resale | |||||||||||||||||||
gain on commercial loans originated for resale | |||||||||||||||||||
gain on sale of ira portfolio | |||||||||||||||||||
income from discontinued operations | |||||||||||||||||||
gain on sales of investment securities | -636,000 | -136,000 | -20,000 | 14,000 | 0 | ||||||||||||||
change in fair value of discontinued loans held-for-sale | |||||||||||||||||||
cash from call of investment securities held-to-maturity | |||||||||||||||||||
proceeds from sale of investment securities available-for-sale | 200,455,000 | 76,003,000 | 265,000 | ||||||||||||||||
proceeds from the issuance of common stock options | |||||||||||||||||||
proceeds from the sale of ira portfolio | |||||||||||||||||||
transfers of discontinued loans to other real estate owned | |||||||||||||||||||
loan transferred in acquisition | |||||||||||||||||||
investment securities transferred in securitization transaction | |||||||||||||||||||
sale of commercial loans originated for resale | |||||||||||||||||||
change in fair value of loans held-for-sale | |||||||||||||||||||
net used in operating activities | |||||||||||||||||||
net used in investing activities | |||||||||||||||||||
benefit from loan and lease losses | 770,000 | 4,844,000 | 5,019,000 | 6,963,000 | 4,672,000 | 4,212,000 | 4,148,000 | 4,000,000 | 3,500,000 | 2,500,000 | 3,000,000 | 3,700,000 | 4,100,000 | 3,350,000 | 1,350,000 | 3,150,000 | |||
gain on sales of commercial loans originated for resale | |||||||||||||||||||
proceeds from redemptions and prepayments of securities held-to-maturity | 0 | ||||||||||||||||||
costs from issuance of common stock | |||||||||||||||||||
non-cash reclassification of commercial loans sold | |||||||||||||||||||
gain on sales of loans originated for resale | -4,800,000 | ||||||||||||||||||
investment securities received in securitization transaction | |||||||||||||||||||
decrease (increase) in discontinued assets held-for-sale | |||||||||||||||||||
net cash from (used) in financing activities | |||||||||||||||||||
adjustments to reconcile net income to net cash from | |||||||||||||||||||
(used in) operating activities | |||||||||||||||||||
change in fair value of loans held for sale | |||||||||||||||||||
change in fair value of discontinued loans held for sale | |||||||||||||||||||
net decrease in discontinued loans held for sale | 7,192,000 | ||||||||||||||||||
decrease (increase) in discontinued assets held for sale | 3,489,000 | ||||||||||||||||||
proceeds (costs) from issuance of common stock | |||||||||||||||||||
net increase in long-term liabilities | |||||||||||||||||||
cash and cash equivalents, beginning of year | 472,319,000 | 0 | 354,459,000 | 0 | 0 | 0 | 179,506,000 | 0 | 0 | 0 | 82,158,000 | 0 | |||||||
cash and cash equivalents, end of year | 338,433,000 | -53,730,000 | 137,829,000 | 63,222,000 | 64,921,000 | -29,229,000 | 80,592,000 | ||||||||||||
transfers of loans to other real estate owned | 990,000 | 2,840,000 | 1,420,000 | 1,489,000 | 1,890,000 | 189,000 | |||||||||||||
change in discontinued assets held for sale | |||||||||||||||||||
decrease (increase) in other liabilities | |||||||||||||||||||
proceeds from redemptions of securities held-to-maturity | |||||||||||||||||||
common stock issuance expense | |||||||||||||||||||
investment securities transferred in securitization | |||||||||||||||||||
sale of loans originated for resale | 4,966,000 | ||||||||||||||||||
writedown of other real estate | |||||||||||||||||||
change in fair value loans held for sale | |||||||||||||||||||
decrease in discontinued assets held for sale | |||||||||||||||||||
investment in unconsolidated entity | 33,238,000 | ||||||||||||||||||
adjustments to reconcile net income to net cash | |||||||||||||||||||
provided by operating activities | |||||||||||||||||||
change in fair value discontinued loans held for sale | |||||||||||||||||||
transfer of loans to held for sale | |||||||||||||||||||
proceeds of short-term borrowings and federal funds purchased | |||||||||||||||||||
proceeds from issuance of common stock | 0 | 0 | -27,000 | 54,528,000 | |||||||||||||||
proceeds from the exercise of common stock options | |||||||||||||||||||
increase in discontinued assets held for sale | |||||||||||||||||||
net cash from by investing activities | |||||||||||||||||||
gainon sales of loans originated for resale | |||||||||||||||||||
gain on sale of investment securities | |||||||||||||||||||
other than temporary impairment on securities held-to-maturity | 0 | ||||||||||||||||||
purchase of investment securities held-to-maturity | |||||||||||||||||||
net increase in securities sold under agreements to repurchase | 8,120,000 | 4,799,000 | 475,000 | 5,400,000 | 4,954,000 | 5,657,000 | -1,188,000 | ||||||||||||
proceeds from the exercise of options | |||||||||||||||||||
losses on sale and write downs on other real estate owned | |||||||||||||||||||
decrease in interest payable | 10,000 | 15,000 | -226,000 | ||||||||||||||||
excess tax benefit from share-based payment arrangements | |||||||||||||||||||
transfers of loans to held for sale | |||||||||||||||||||
common stock shares issued, cashless transaction | |||||||||||||||||||
mortgage loans originated for sale | 0 | 0 | 0 | -458,000 | 0 | -182,000 | -213,000 | -3,795,000 | -1,787,000 | 0 | -181,000 | -1,220,000 | -3,615,000 | ||||||
sale of mortgage loans originated for resale | 0 | 0 | 8,000 | 454,000 | 0 | 1,381,000 | 0 | 183,000 | 1,246,000 | 3,605,000 | |||||||||
gain on sales of mortgage loans originated for resale | 0 | -3,000 | |||||||||||||||||
(gain) loss on sales of fixed assets | 1,000 | -18,000 | -6,000 | -2,000 | 16,000 | ||||||||||||||
other than temporary impairment on securities available-for-sale | 75,000 | 0 | |||||||||||||||||
proceeds from call of securities held-to-maturity | 0 | 0 | |||||||||||||||||
proceeds from redemptions and repayment of securities available for sale | |||||||||||||||||||
proceeds from sales of fixed assets | 11,000 | 87,000 | |||||||||||||||||
(repayment) proceeds from short-term borrowings | -100,000,000 | ||||||||||||||||||
purchase of treasury stock | |||||||||||||||||||
redemption of preferred stock | 0 | ||||||||||||||||||
repurchase of warrants | 1,000 | ||||||||||||||||||
dividends paid on series a and b preferred stock | 0 | -433,000 | -735,000 | -565,000 | |||||||||||||||
gain on sale of mortgage loans originated for resale | 0 | 0 | -4,000 | -5,000 | 0 | -2,000 | |||||||||||||
deferred income tax benefit | |||||||||||||||||||
loss on sales of other real estate owned | 64,000 | 439,000 | 52,000 | ||||||||||||||||
proceeds from redemptions and repayment of securities available-for-sale | 26,033,000 | ||||||||||||||||||
repayment of short-term borrowings and federal funds purchased | 0 | 0 | -136,000,000 | ||||||||||||||||
dividends paid on series b preferred stock | |||||||||||||||||||
increase in interest payable | -18,000 | 25,000 | -2,061,000 | 264,000 | 1,519,000 | ||||||||||||||
proceeds from redemptions and repayment on securities available-for-sale | 38,275,000 | 9,407,000 | 26,747,000 | 5,028,000 | |||||||||||||||
proceeds from sales of investment securities available-for-sale | 12,302,000 | 10,438,000 | 58,315,000 | ||||||||||||||||
impairment of goodwill | |||||||||||||||||||
gain on sales of fixed assets | 35,000 | 0 | 0 | -1,000 | |||||||||||||||
proceeds (repayment) from short-term borrowings | |||||||||||||||||||
proceeds from issuance of preferred stock | |||||||||||||||||||
repayment of short-term borrowings | |||||||||||||||||||
repayment of preferred stock | -45,220,000 | ||||||||||||||||||
(gain) loss on sale of investment securities | |||||||||||||||||||
net gain on sales of loans | |||||||||||||||||||
(decrease) in interest payable | |||||||||||||||||||
(repayment) proceeds from short term borrowings | |||||||||||||||||||
proceeds from issuance of common stock, net of cost | |||||||||||||||||||
proceeds from issuance of subordinated debt | |||||||||||||||||||
net proceeds from the exercise of share based payments | |||||||||||||||||||
excess tax benefits from share based payment arrangements | |||||||||||||||||||
transfer of assets from loans to other real estate owned | |||||||||||||||||||
sales of mortgage loans originated for resale | 420,000 | ||||||||||||||||||
other than temporary impairment | |||||||||||||||||||
cash and cash equivalents, end of the period | |||||||||||||||||||
other than temporary impairment on securities available for sale | |||||||||||||||||||
purchase of investment securities available for sale | -67,474,000 | -43,926,000 | |||||||||||||||||
proceeds from redemptions and repayment on securities available for sale | |||||||||||||||||||
proceeds from the sales of investment securities available for sale | |||||||||||||||||||
proceeds from the sale of other real estate owned | |||||||||||||||||||
proceeds from redemptions and repayment available for sale | 41,223,000 | ||||||||||||||||||
net gain on sales of fixed assets | -1,000 | ||||||||||||||||||
dividends on series a and b preferred stock | -412,000 | ||||||||||||||||||
net cash provided(used in) by financing activities | -24,906,000 | ||||||||||||||||||
other than temporary impairment on investment securities | 11,611,000 | ||||||||||||||||||
net income on sales of investment securities | |||||||||||||||||||
stock-based compensation | |||||||||||||||||||
proceeds from redemptions and repayments available for sale | |||||||||||||||||||
proceeds from calls/maturity of investment securities available for sale | |||||||||||||||||||
(payments) proceeds from short term borrowings | |||||||||||||||||||
excess tax benefit from share based payment arrangements | |||||||||||||||||||
issuance of subordinated debentures | |||||||||||||||||||
transfer of investment securities available for sale to held to maturity | |||||||||||||||||||
accretion/amortization of investment securities discounts/premiums | |||||||||||||||||||
(increase) in other assets | |||||||||||||||||||
purchase of investment securities, available for sale | |||||||||||||||||||
proceeds from sales of investment securities, available for sale | |||||||||||||||||||
purchase of loans | |||||||||||||||||||
net decrease (increase) in securities sold under agreements to repurchase | |||||||||||||||||||
proceeds from short term borrowings | -50,000,000 | ||||||||||||||||||
dividends on series a preferred stock | -16,000 | -16,000 | -17,000 | -16,000 | |||||||||||||||
proceeds from long term borrowings | 8,250,000 | ||||||||||||||||||
supplemental disclosure of non -cash investing and financing activities: | |||||||||||||||||||
transfer of loans to other real estate owned | |||||||||||||||||||
net (loss)/income | |||||||||||||||||||
amortization of investment securities discounts/premiums | |||||||||||||||||||
gain on sales of investment security | |||||||||||||||||||
purchase of investment securities | -6,941,000 | -5,398,000 | -18,640,000 | ||||||||||||||||
proceeds from maturities of and repayments on investment securities | |||||||||||||||||||
increase in loans | |||||||||||||||||||
net gain on sales of investment securities | |||||||||||||||||||
loss on sale of mortgage loans originated for resale | -10,000 | ||||||||||||||||||
proceeds from sales of investment securities | 1,353,000 | ||||||||||||||||||
proceeds (payment) from federal home loan bank advances | 85,000,000 | ||||||||||||||||||
net proceeds from the exercise of options | 47,000 | ||||||||||||||||||
issuance of long term borrowings | 15,000,000 | ||||||||||||||||||
proceeds from calls/maturity of investment securities | -274,000 | ||||||||||||||||||
proceeds from federal home loan bank advances | |||||||||||||||||||
repayment of notes payable | |||||||||||||||||||
net proceeds from exercise of warrants | |||||||||||||||||||
redemption of subordinated debentures | |||||||||||||||||||
net (decrease) cash from financing activities | |||||||||||||||||||
net share settlement of warrants | |||||||||||||||||||
acquisition of stored value solutions, common stock issued | |||||||||||||||||||
net amortization | |||||||||||||||||||
share based compensation expense | |||||||||||||||||||
net increase from federal funds purchased | |||||||||||||||||||
net increase from federal home loan advances | |||||||||||||||||||
supplemental disclosure of noncash investing and financing activities: | |||||||||||||||||||
transfer of loans to other real estate owned. | |||||||||||||||||||
increase in accrued interest payable | |||||||||||||||||||
cash paid in excess of cash equivalents from acquisition | |||||||||||||||||||
net proceeds (payments) from federal home loan bank advances | |||||||||||||||||||
dividends paid on series a preferred stock | |||||||||||||||||||
net proceeds from sale of common stock | |||||||||||||||||||
mortgage loans originated for resale | |||||||||||||||||||
net increase(decrease) in securities sold under agreements to repurchase | |||||||||||||||||||
federal home loan bank advances | |||||||||||||||||||
repayment of federal home loan advances | |||||||||||||||||||
net cash from (used in ) operating activities | |||||||||||||||||||
net increase in securities sold under agreements to | |||||||||||||||||||
repurchase | |||||||||||||||||||
cash dividends on series a preferred stock |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
